Child vaccine schedule
Pro Research Analysisby 
Searched over 200M research papers
Child Vaccine Schedule: Key Insights and Recommendations
Overview of Child Vaccine Schedules
The Advisory Committee on Immunization Practices (ACIP) regularly updates the recommended immunization schedule for children and adolescents aged 18 years or younger in the United States. These schedules are endorsed by several major health organizations, including the CDC, the American Academy of Pediatrics, and the American Academy of Family Physicians Wodi2022Robinson2017Wodi2023+3 MORE. The schedules are designed to protect children from various infectious diseases by ensuring timely vaccination.
Influenza Vaccine Schedule for Young Children
For children aged 6 to 23 months, the trivalent inactivated influenza vaccine (TIV) is recommended. A study compared the standard two-dose regimen administered in the fall with an early schedule of a single spring dose followed by a fall dose. The results showed that both schedules had similar immunogenicity and reactogenicity, suggesting that initiating the vaccine in the spring could facilitate earlier full immunization .
Pneumococcal Conjugate Vaccine (PCV) Schedules
UK Infants: PCV13 Schedules
A study in the UK compared the immunogenicity of two different PCV13 schedules in infants: the standard 2+1 schedule (doses at 2, 4, and 12 months) and a reduced 1+1 schedule (doses at 3 and 12 months). The findings indicated that for most serotypes, the 1+1 schedule was either equivalent or superior in immunogenicity compared to the 2+1 schedule. This suggests that a reduced schedule could maintain population control of pneumococcal disease in countries with established herd immunity .
Vietnam Infants: PCV10 Schedules
In Vietnam, a study compared four different PCV10 schedules. The results showed that a two-dose primary series was non-inferior to a three-dose primary series for most serotypes. Additionally, a wider interval between doses increased immunogenicity. This suggests that a two-dose primary schedule with a wider interval could be effective in low-income and middle-income countries .
Meningococcal Serogroup B Vaccine (4CMenB) Schedules
A study evaluated the immunogenicity and safety of the 4CMenB vaccine administered according to reduced schedules in infants and catch-up series in children. The findings demonstrated that reduced infant schedules and catch-up series were both immunogenic and safe, potentially widening vaccine coverage .
Conclusion
The recommended immunization schedules for children are continually updated to reflect the latest research and ensure optimal protection against infectious diseases. Studies on alternative schedules for vaccines like TIV, PCV, and 4CMenB provide valuable insights that can help optimize vaccination strategies, ensuring both efficacy and safety. Health care providers should stay informed about these updates to provide the best care for their pediatric patients.
Sources and full results
Most relevant research papers on this topic